Semnur Pharmaceuticals 

Denali Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to complete a business combination with companies primarily operating in the technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.